Swiss National Bank Ani Pharmaceuticals Inc Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Swiss National Bank holds 32,800 shares of ANIP stock, worth $1.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,800

Previous 33,100 0.91%

Holding current value

$1.85 Million

Previous $2.11 Million 7.17%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$54.33 - $65.72 $16,299 - $19,716	-300 Reduced 0.91%	32,800 $1.96 Million
Q2 2024 Aug 08, 2024	BUY	$58.53 - $68.82 $46,824 - $55,055	800 Added 2.48%	33,100 $2.11 Million
Q1 2024 May 07, 2024	BUY	$54.2 - $69.69 $124,660 - $160,287	2,300 Added 7.67%	32,300 $2.23 Million
Q4 2023 Feb 06, 2024	SELL	$48.72 - $65.43 $267,960 - $359,865	-5,500 Reduced 15.49%	30,000 $1.65 Million
Q3 2023 Nov 08, 2023	BUY	$50.28 - $64.61 $155,868 - $200,291	3,100 Added 9.57%	35,500 $2.06 Million
Q2 2023 Aug 09, 2023	BUY	$37.29 - $53.83 $156,618 - $226,086	4,200 Added 14.89%	32,400 $1.74 Million
Q1 2023 May 10, 2023	SELL	$37.61 - $45.72 $124,113 - $150,876	-3,300 Reduced 10.48%	28,200 $1.12 Million
Q4 2022 Feb 08, 2023	BUY	$31.9 - $41.95 $25,520 - $33,560	800 Added 2.61%	31,500 $1.27 Million
Q3 2022 Nov 09, 2022	BUY	$29.83 - $38.01 $32,813 - $41,811	1,100 Added 3.72%	30,700 $987,000
Q2 2022 Aug 09, 2022	BUY	$23.09 - $33.46 $60,034 - $86,996	2,600 Added 9.63%	29,600 $878,000
Q1 2022 May 09, 2022	BUY	$26.91 - $47.15 $48,438 - $84,870	1,800 Added 7.14%	27,000 $759,000
Q4 2021 Feb 08, 2022	BUY	$32.97 - $56.85 $89,019 - $153,495	2,700 Added 12.0%	25,200 $1.16 Million
Q3 2021 Nov 08, 2021	BUY	$26.48 - $35.99 $18,536 - $25,193	700 Added 3.21%	22,500 $738,000
Q2 2021 Aug 06, 2021	SELL	$31.86 - $38.6 $19,116 - $23,160	-600 Reduced 2.68%	21,800 $764,000
Q3 2020 Nov 09, 2020	BUY	$26.38 - $33.1 $21,104 - $26,480	800 Added 3.7%	22,400 $632,000
Q2 2020 Aug 05, 2020	BUY	$29.93 - $50.1 $125,706 - $210,420	4,200 Added 24.14%	21,600 $699,000
Q4 2019 Feb 06, 2020	BUY	$55.65 - $79.83 $22,260 - $31,932	400 Added 2.35%	17,400 $1.07 Million
Q3 2019 Nov 12, 2019	BUY	$64.7 - $85.39 $32,350 - $42,695	500 Added 3.03%	17,000 $1.24 Million
Q2 2019 Aug 02, 2019	BUY	$67.77 - $82.2 $20,331 - $24,660	300 Added 1.85%	16,500 $1.36 Million
Q1 2019 May 10, 2019	BUY	$45.83 - $70.54 $22,915 - $35,270	500 Added 3.18%	16,200 $1.14 Million
Q4 2018 Feb 13, 2019	BUY	$41.17 - $56.44 $37,053 - $50,796	900 Added 6.08%	15,700 $707,000
Q3 2017 Nov 03, 2017	BUY	$43.46 - $52.49 $643,208 - $776,852	14,800	14,800 $777,000

Others Institutions Holding ANIP

# of Institutions

212

Shares Held

18.8M

Call Options Held

11.7K

Put Options Held

10.5K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $982M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Ani Pharmaceuticals Inc Transaction History